Genetic Determinants of Kidney Disease in People of African Ancestry With HIV

NCT05685810 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 3029

Last updated 2025-09-03

No results posted yet for this study

Summary

Black ethnicity is a major risk factor for chronic kidney disease \[CKD\] in people with HIV infection, suggesting that genetic factors are an important determinant of kidney disease progression in this population. The Gen-Africa study was established in 2018 to allow the study of genetic and clinical risk factors for CKD in people with HIV in the UK. Just over 3000 people across 15 sites were enrolled between May 2018 and January 2020. Demographic and clinical information was collected, and biological samples (buffy coats, plasma and urine) obtained. Cross-sectional analyses have revealed that participants of West-African ancestry are at higher risk of CKD and end-stage kidney disease \[ESKD\], and that genetic variants in the apolipoprotein L1 (APOL1) gene and sickle cell trait (SCT) are predictors of CKD and ESKD. The pathogenesis of APOL1- and SCT-associated CKD is incompletely understood, and additional, longitudinal data will be collected to improve understanding of the contribution of demographic, traditional CKD (diabetes, hypertension, obesity/metabolic syndrome, cardiovascular disease) and HIV (immuno-virological and hepatitis B/C co-infection status, antiretroviral medications) risk factors as well as additional genetic and epigenetic markers.

Conditions

Sponsors & Collaborators

  • Guy's and St Thomas' NHS Foundation Trust

    collaborator OTHER
  • Lewisham and Greenwich NHS Trust

    collaborator OTHER_GOV
  • Royal Free Hospital NHS Foundation Trust

    collaborator OTHER
  • Central and North West London NHS Foundation Trust

    collaborator OTHER
  • Barts & The London NHS Trust

    collaborator OTHER
  • Chelsea and Westminster NHS Foundation Trust

    collaborator OTHER
  • Imperial College Healthcare NHS Trust

    collaborator OTHER
  • North Middlesex University Hospital NHS Trust

    collaborator OTHER_GOV
  • Brighton and Sussex University Hospitals NHS Trust

    collaborator OTHER
  • The Leeds Teaching Hospitals NHS Trust

    collaborator OTHER
  • Manchester University NHS Foundation Trust

    collaborator OTHER_GOV
  • Newcastle-upon-Tyne Hospitals NHS Trust

    collaborator OTHER
  • South Tees Hospitals NHS Foundation Trust

    collaborator OTHER
  • Africa Advocacy Foundation

    collaborator UNKNOWN
  • Vanderbilt University

    collaborator OTHER
  • University of Cape Town

    collaborator OTHER
  • University of Pennsylvania

    collaborator OTHER
  • Medical Research Council

    collaborator OTHER_GOV
  • British HIV Association

    collaborator UNKNOWN
  • Gilead Sciences

    collaborator INDUSTRY
  • St George's Healthcare NHS Trust

    collaborator OTHER
  • Guy's & St Thomas' Charity

    collaborator OTHER
  • King's College Hospital NHS Trust

    lead OTHER

Principal Investigators

  • Frank A Post · King's College Hospital NHS Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-01
Primary Completion
2020-01-31
Completion
2030-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05685810 on ClinicalTrials.gov